The-Business-Research-Company-horizontal-logo-2.png
Inactivated Vaccines Market Set to Reach $7.3 Billion in 2028 - Global Growth Driven by Immunization Initiatives and Advancements in Biomanufacturing As Per The Business Research Company's Inactivated Vaccines Global Market Report 2024
January 18, 2024 11:30 ET | TBRC Business Research PVT LTD
LONDON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Inactivated Vaccines Global Market Report 2024, the inactivated vaccines market has exhibited consistent growth, with...
cmi_logo.png
[Latest] Global Microelectronics Market Size/Share Worth USD 934.4 Billion by 2032 at a 8.75% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
January 18, 2024 11:30 ET | Custom Market Insights
Austin, TX, USA, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Microelectronics Market Size, Trends and Insights By Algorithm (Behavioral,...
The-Business-Research-Company-horizontal-logo-2.png
Automotive 48V System Market Is Expected To Reach $17.8 Billion By 2028 At A CAGR Of More Than 25% As Per The Business Research Company's Automotive 48V System Global Market Report 2024
January 18, 2024 11:30 ET | TBRC Business Research PVT LTD
LONDON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Automotive 48V System Global Market Report 2024, the automotive 48V system market has witnessed exponential growth,...
Failure Analysis Market Surges, Projected to Reach US$ 15 Billion by 2033 with 7.4% CAGR, According to Persistence Market Research
January 18, 2024 11:30 ET | Persistence Market Research
New York, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The projected value of the global failure analysis equipment market is anticipated to reach US$ 7.3 billion by 2023, with a compound annual growth rate...
The-Business-Research-Company-horizontal-logo-2.png
Nivolumab Market Overview 2024-2028: Global Expansion Driven By Immunotherapy Advancements And Rising Cancer Incidence As Per The Business Research Company's Nivolumab Global Market Report 2024
January 18, 2024 11:30 ET | TBRC Business Research PVT LTD
LONDON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Nivolumab Global Market Report 2024, nivolumab market has experienced remarkable growth in recent years and is set to...
PBI vertical.jpg
Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order
January 18, 2024 11:26 ET | Pressure BioSciences, Inc.
With the Recent Acquisition of Its New Uncle Buds Business Unit, PBIO Expects Consumer Products to Continue Their Rapid Sales Acceleration
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Golden Heaven Group Holdings Ltd. of Class Action Lawsuit and Upcoming Deadlines – GDHG
January 18, 2024 11:23 ET | Pomerantz LLP
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Golden Heaven Group Holdings Ltd. (“Golden Heaven” or the “Company”) (NASDAQ:...
download.jpg
DocGo (DCGO) Tanks After Fuzzy Panda Research Alleges Fraudulent Billing & Forgery – Hagens Berman
January 18, 2024 11:21 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DocGo Inc. (NASDAQ: DCGO) investors who suffered substantial losses to submit your losses now. Visit:...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Assertio Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – ASRT
January 18, 2024 11:19 ET | Pomerantz LLP
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT). The class...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines – BNTX
January 18, 2024 11:15 ET | Pomerantz LLP
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against BioNTech SE (“BioNTech” or the “Company”) (NASDAQ: BNTX). The class action,...